Federico Mattiello
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials.
Journal: EJHaem
Published: March 10, 2023
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma.
Journal: Blood
Published: July 09, 2020
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA.
Journal: Blood advances
Published: June 16, 2020
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
Journal: American journal of hematology
Published: March 09, 2020
An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma.
Journal: Contemporary clinical trials
Published: October 29, 2018
Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 28, 2018
A broken promise: microbiome differential abundance methods do not control the false discovery rate.
A broken promise: microbiome differential abundance methods do not control the false discovery rate.
Journal: Briefings in bioinformatics
Published: January 18, 2017
Last Updated: 09/26/2026